$1.93
-0.01-0.52%
Pre-Market: 7:59 PM EDT
Comments
Loading...
Reviva Pharmaceuticals (NASDAQ:RVPH) Stock, Earnings Estimates, EPS, And Revenue
Reviva Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 14
EPS Estimate
$-0.210
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Reviva Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Reviva Pharmaceuticals (RVPH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.25 | $-0.25 | 0.00 % |
| Q2 | 2024-08-14 | $-0.26 | $-0.29 | 10.3 % |
| Q1 | 2024-05-14 | $-0.25 | $-0.42 | 40.5 % |
| Q4 | 2024-04-15 | $-0.35 | $-0.32 | -9.38 % |
Reviva Pharmaceuticals (RVPH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals (RVPH) is scheduled to report earnings on April 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Reviva Pharmaceuticals (NASDAQ:RVPH)?
The Actual EPS was $-0.25, which hit the estimate of $-0.25.
What were Reviva Pharmaceuticals’s (NASDAQ:RVPH) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.